1e
19
1
49
2
2
18
1b
1d
18
2f
60
1d
2 29
1d
25
Alice S. Pang, MD
88
60
Assistant Professor of Clinical Medicine (Gastroenterology)
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
49
4
3
3
3
2
4
b
1f
49
3400 Civic Center Boulevard
23 Perelman School of Medicine
3d South Pavilion - 7th Floor
Philadelphia, PA 19104
26
23 Perelman School of Medicine
3d South Pavilion - 7th Floor
Philadelphia, PA 19104
2e
Office: 215-349-8222
30
f
30
13
Education:
21 7 BA 14 (Biology) c
2a Dartmouth College, 2012.
21 7 MD 1f (Doctor of Medicine) c
4e The University of Chicago Pritzker School of Medicine, 2017.
c
3
3
3
3
8d
Permanent link21 7 BA 14 (Biology) c
2a Dartmouth College, 2012.
21 7 MD 1f (Doctor of Medicine) c
4e The University of Chicago Pritzker School of Medicine, 2017.
c
2 29
21
1e
1d
24
2b
29
27
23
18a Pang A, Halegoua-De Marzio DL, Sass DA, Shah AP, Singh P, Powers T, Ryan M, Fenkel J. (2022). : Transplant Evaluation Practices for Kidney Donors and Recipients with History of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States. Gastroenterology 162(7): S-1293, 2022.
115 Pang A, Boortalary T, Au C, Henry C, Infantolino A, Tofani C. : The Effect of Weekend versus Weekday Admission on Outcomes of Suspected Small Bowel Bleeding. Gastrointest Endosc 95 (6), 2022 Notes: AB450.
13a Hong SJ, Zenger C, Pecoriello J, Pang A, Vallely M, Hudesman DP, Chang S, Axelrad JE. : Ustekinumab and Vedolizumab Are Not Associated with Subsequent Cancer in IBD Patients with Prior Malignancy. Inflamm Bowel Dis. 28(12): 1826-1832, 2022.
166 Tapaskar N, Pang A, Werner DA, Sengupta N. : Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis. Dig Dis Sci. 66(2): 554-566. 2021.
114 Pang A, Chang S, Axelrad J. : Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Vedolizumab or Ustekinumab. Am J Gastroenterol 647: 114, Oct 2019.
eb Mujumdar S, Goldenberg J, Bieser S, Pang AS, Coben R.: Cholestatic Liver Injury in a Patient with Tertiary Syphilis. Case Rep Gastroenterol 16: 552-556, Sep 2022.
102 Pang A, Zeineddine HA: Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. Cerebrovasc Dis. 43(5-6): 223-230, 2017.
16e Wood M, Rawe M, Johansson G, Pang S, Soderquist R, Patel A, Nelson S, Seibel W, Ratner N, Sanchez Y. : Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cell lines. Mol Cancer Ther. 10(9): 1740-1750, 2011
2c
7
1d
1f
Selected Publications
150 Manski S, Schmoyer C, Pang A, Lieberman J, Gernhardt M, Murugesan N, Leto A, Erwin R, Kavanagh T, Conn M. : The Safety of the Re-opening of an Academic Medical Center Outpatient Endoscopy Unit During the COVID-19 Pandemic. Gastroenterol Res. 15(4): 200-206, 2022.18a Pang A, Halegoua-De Marzio DL, Sass DA, Shah AP, Singh P, Powers T, Ryan M, Fenkel J. (2022). : Transplant Evaluation Practices for Kidney Donors and Recipients with History of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States. Gastroenterology 162(7): S-1293, 2022.
115 Pang A, Boortalary T, Au C, Henry C, Infantolino A, Tofani C. : The Effect of Weekend versus Weekday Admission on Outcomes of Suspected Small Bowel Bleeding. Gastrointest Endosc 95 (6), 2022 Notes: AB450.
13a Hong SJ, Zenger C, Pecoriello J, Pang A, Vallely M, Hudesman DP, Chang S, Axelrad JE. : Ustekinumab and Vedolizumab Are Not Associated with Subsequent Cancer in IBD Patients with Prior Malignancy. Inflamm Bowel Dis. 28(12): 1826-1832, 2022.
166 Tapaskar N, Pang A, Werner DA, Sengupta N. : Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis. Dig Dis Sci. 66(2): 554-566. 2021.
114 Pang A, Chang S, Axelrad J. : Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Vedolizumab or Ustekinumab. Am J Gastroenterol 647: 114, Oct 2019.
eb Mujumdar S, Goldenberg J, Bieser S, Pang AS, Coben R.: Cholestatic Liver Injury in a Patient with Tertiary Syphilis. Case Rep Gastroenterol 16: 552-556, Sep 2022.
102 Pang A, Zeineddine HA: Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. Cerebrovasc Dis. 43(5-6): 223-230, 2017.
16e Wood M, Rawe M, Johansson G, Pang S, Soderquist R, Patel A, Nelson S, Seibel W, Ratner N, Sanchez Y. : Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cell lines. Mol Cancer Ther. 10(9): 1740-1750, 2011
2c